Navigation Links
2 children suffering from adrenoleukodystrophy saved thanks to the ELA Association
Date:11/5/2009

The ELA association and Zinedine Zidane, its emblematic ambassador, are proud to announce a world premiere: the results regaring the gene therapy in adrenoleukodystrophy conducted in France have just been published in the prestigious journal Science. Two children have been treated and their diseases have been halted. The children are doing well, which is unexpected for a disease destroying the brain in a few months. This discovery opens up treatment perspectives for numerous widespread diseases.

Gene therapy on adrenoleukodystrophy: a world premiere

Adrenoleukodystrophy (ALD) is the most frequent form of leukodystrophies. It affects nearly 30 % of leukodystrophy cases identified by the ELA association. Each year, 35 babies with adrenoleukodystrophy are born in France, but death often occurs during childhood.

Until now, the treatment for ALD relied on bone marrow transplant, an approach which is limited by the scarcity of donors and the risk of serious complications. With this new approach, physicians have chosen to perform an autologous graft combined with gene therapy. For this procedure, the bone marrow stem cells of the patients are harvested, and then corrected in the laboratory before being transplanted back into the patients. Some of these cells will naturally find their way to the patient's brain where they will display their correcting potential. Another innovation: a vector derived from a modified and inactivated HIV virus was used to insert the correct gene into bone marrow cells. HIV represents the only virus able to introduce a therapeutic gene into the nucleus of non-dividing cells, like stem cells and neurons, in order to allow a long-term effect of this gene.

With 7 million Euros invested, ELA is the largest funder for research on ALD

These very large amounts of money have been gathered thanks to the actions undertaken by millions of school children, to the support of the French Ministry of Research, to the generosity of all the donors. Also, the involvement of our partners and ambassadors, led by Zinedine Zidane and Florent Pagny, contribute to this success.

A discovery that will benefit to widespread diseases

Today, ELA is even prouder of this result because this innovative approach opens up treatment perspectives for other types of leukodystrophies and most importantly to other widespread diseases (sickle cell anemia, beta-thalassemia and multiple immunodeficiencies, hemophilia, Parkinson's disease, ) which could benefit from a similar gene therapy treatment using a HIV-derived vector.

Founded in 1992 by Guy Alba, parent of a child with ALD, with the encouragement of Pr. Aubourg, chairman of the scientific committee until 2008, ELA brings together European families affected by leukodystrophies, a group of genetic diseases that destroy the myelin (nerve sheath) in the brain. Since its creation, ELA pursues the same goals: support patients, gather families and fund medical research. To accelerate the discovery of a treatment, ELA founded its own research foundation in 2005 with the support of the French Ministry of Research. The foundation's efforts and momentum permitted dedicating 30 million Euros for all kind of leukodystrophies.

Concomitantly, ELA cares for patients and brings special attention to those who may not benefit from research advances. That's why ELA commits 4.3 million Euros for the support of patients and their families needs. With the same motivations, ELA supports the development of similar organizations in Europe (Belgium, Spain, France, Italy, Luxembourg, and Switzerland).

And ELA is planning for more

  1. extend the trial in Europe and recruit new patients including adults
  2. develop a newborn screening test
  3. offer the therapy to all ALD patients

Testimony of Guy Alba, founder and president of the ELA association (ELA) and parent of a child suffering from adrenoleukodystrophy (ALD)

I met Pr. Patrick Aubourg for the first time in 1991, when he diagnosed my 5 year-old son with adrenoleukodystrophy. I knew precisely the damages caused by this horrible disease (loss of motor function, of vision, speech, hearing, memory...) because they were destroying my nephew, 5 years older than my son, prefiguring what will happen to my little boy. Although petrified by this astounding news, it seemed nevertheless inconceivable to passively wait for the worst to come. I had long conversations with Patrick Aubourg who encouraged me to create a patient organization and accepted to chair its scientific committee. This is how ELA was born in 1992.

17 years later, the present victory over adrenoleukodystrophy bears the marks of all these fighting years, pains, losses, but also of numerous moments of solidarity and happiness. This victory against the disease is due first and foremost to the great research team lead by Pr. Patrick Aubourg and Dr. Nathalie Cartier. We also owe this victory to the tenacity of the highly committed ELA families who held on during all this time. We are furthermore indebted to the thousands of school children involved each year for ELA, to all our donors, all our partners, and if there was only a single one to name, to Zinedine Zidane, given his personal level of involvement and care.

Thanks to him and to them, ELA was able to fund ALD research at both national and European levels, but in the US as well, globally in a quite exceptional manner (7 million Euros invested so far), and to continuously support Pr. Aubourg's team since 1992.

All ELA families were impatiently waiting for this major breakthrough even those who do not expect anything from this discovery because the disease has already taken everything away from them. Today we are even prouder of this result because gene therapy on ALD opens up treatment perspectives for numerous other diseases that are more widespread. The children of ELA have thereby contributed to open the way for a new therapy which, we truly hope, will be useful to many other sick children and adults suffering from many kinds of diseases. It will be our best reward. .


'/>"/>

Contact: Guy Alba
guy.alba@ela-asso.com
33-383-309-810
ELA association
Source:Eurekalert  

Related medicine news :

1. Chelation Therapy Drug Found Safe and Beneficial for Children With Autism
2. The Minnesota Nurses Association: School Nurses in Minnesota Celebrate 100 Years of Addressing Health Needs of School Children
3. Behavioral Testing for Children Now Offered at Marianjoy
4. Childrens and Its Physicians Join Forces With Insurers to Accelerate Transformation of Pediatric Care to a More Effective and Efficient Health Care Delivery System
5. Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Childrens Research Hospital(R)
6. Married With Children Paves Way to Happiness
7. Study: Lap band surgery effective for morbidly obese children
8. Nearly half of all US children will use food stamps, says poverty expert at WUSTL
9. The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer
10. Children's Hospital Physician Honored for Research
11. More Than 250 West Philadelphia Men, Women and Children are Expected to Attend Wellness for Life Event
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2 children suffering from adrenoleukodystrophy saved thanks to the ELA Association
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
Breaking Medicine Technology: